I graduated in Clinical Engineering at Rome University "La Sapienza” in November 2017. Then I have studied Biomedical Engineering in the same university. Currently I’m working on my Master thesis in cooperation with the ARPG “Applied Radiation Physics Group” . My thesis is focused on the study of inter-fractional monitoring in particle therapy with the Dose Profiler detector.
Researcher of the Dept of Physics of the University of Rome La Sapienza. Graduated in 2000 the KLOE experiment, he spent his PhD in the Babar experiment working on the Flavour Changinf Neutral Currents rare decays. Since 2007 he is devoted to the search of the Neutrinoless Double Beta Decay within the CUORE and LUCIFER experiments.
He's working on the proton production induced by Laser Plasma Accelerated electrons on target.
Graduated in Medical Physics in Naples with a thesis on a prototype of Single Photon Emission Computed Tomography (SPECT) for small animals imaging. Then she started a PhD in the same field, spending one of the three years at Institute of Experimental and Applied Physics of Czech Technical University of Prague. She worked on a prototype of a Computed Tomography (CT) for small animals imaging, exploiting phase contrast imaging and comparing different imaging detectors. After the PhD she worked for 3 years in Livorno’s Hospital, with a grant from Tuscany Region to set-up and run a Calibration Centre for Ionizing Radiations. Her work has been accredited from the Italian Primary Metrological Institute, ACCREDIA/ENEA. In the mean time, she studied to achieve the title of Medical Physicist in Pisa University. From August 2013 she joined the Applied Radiation Physics Group andworked for one year to develop a dose monitor prototype for hadrontherapic treatments.
I studied Biomedical Engineering at Rome University "Sapienza", I graduated in March, 2013.
My thesis work, carried out in the ARPG group, has been performed in the framework of the TOP-Implart project, whose purpose is the realization of a hadrontherapy center at the National Cancer Institute Regina Elena, IFO. I studied, by means of Monte Carlo simulations with the FLUKA code, the distribution of the dose released by particles escaping from the beampipe in the environment where the linear accelerator will be installed, and I evaluated the efficiency of several shielding systems.
I'm a PhD student in accelerator physics at the Department of Physics of the University of Rome "Sapienza " and I am working on the optimization of laser-plasma acceleration techniques, for a possible use in hadronterapy.
In particular, my PhD work focuses on the study of the photoproduction process obtained by the impact of high-energy electron beam on solid target and of the characteristics of the proton beam produced by this interaction.
I studied particle physics at the University of Rome ”Tor Vergata”. I graduated within the ATLAS group of Tor Vergata working on the development of a new generation of RPCs gas detector for heavy irradiation environments applications. My research activity during the PhD has been focused on the study of the nuclear fragmentation processes in the interaction of light ion beams with different thin targets. In particular I dealt with the analysis of the data acquired at GSI laboratories with the FIRST (Fragmentation of Ions Relevant for Space and Therapy) experiment, for the measurement of fragmentation differential cross sections. Currently, my post-doc activity focus on the measurements of secondary particles produced in the interaction of ion beams with therapeutical energies with PMMA target, in order to study the feasibility of an on-line monitor for particle therapy treatment.
Young research physicist with 3-year experience in model building and validation of predictive modelling of radiation induced toxicity. He is currently working at National Cancer Institute of Milan.
His research activity began in the field of high-energy particle physics, where he acquired deep knowledge of the techniques for the analysis and modelling of complex multi-variable systems. During his thesis, he focused his studies on the field of applied physics to medicine, particularly on the possibility to develop a new compact machine for hadron-therapy.
His present activity is mainly focused on the analysis of the side effects after prostate cancer radiotherapy treatment. He is involved in national (DUE-01 & DUE-02 trial) and international collaboration on modelling of gastrointestinal toxicities (REQUITE project from European Community and Karolinska Hospital, Stockholm) and genitourinary toxicities (Memorial Sloan Kettering Cancer Centre, New York).
Since 2015 he works in the validation of previously published model of intestinal and urinary radioinduced toxicities, including also a process of integration of factors coming from imaging derived features and gene-expression profile. He is now attending the physics PhD school of University of Pavia, where he is developing a new Monte Carlo simulation model for chromosomal aberration.
I studied particle physics at the University “La Sapienza” in Rome.I graduated with a thesis that is about the calibration of the CMS calorimeter at Cern. Now I am taking my Ph.D. in the CHIRONE experiment, finalized to the creation of an intraoperative beta- probe, an useful tool for surgeons in order to minimize the healthy tissue that is removed after the extraction of the tumor mass.
I am a particle physics student and I am oriented towards the medical physics field. Currently I’m writing a thesis about the reconstruction software of a dose profiler for hadrontherapy treatments.
I'm a biomedical engineering student at Roma University "Sapienza" and i graduated in 2010 in clinical engineering.
Currently, i'm working on my thesis on the possible use of the beta probe during radio-guided surgery on brain tumours, like meningiomas and gliomas.
Elisabetta Verdolino NOW ATTENDING THE SPECIALIZATION SCHOOL IN MEDICAL PHYSICS (ROME)
I joined the ARPG group in March 2016. I am currently working on FOOT experiment (FragmentatiOn Of Target). This experiment aims for a precise determination of the contribution to the RBE in proton treatments of the fragmentation induced by the primary beam that interacts with the patient body in the entrance channel. My work in based on the study of the measurement of the production of fragments with very low energy, and very short range (few tens of microns) and also on the feasibility study of an approach based on the measurement of the inverse kinematic reaction and the discussion of the needed experimental resolution on the fragments four momentum.
Debora Giovagnoli NOW PH.D STUDENT AT ÉCOLE DOCTORALE IMT-ATLANTIQUE (BREST & NANTES)
I joined the ARPG group in 2016. I am a graduating student working on the realization of a phoswich detector for the FOOT experiment. My work will be used to assess the feasibility of the implementation of such technology in FOOT, in order to fulfill the requirements on the precision of fragmentation cross sections needed for hadrontherapy applications.